nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylcysteine—SLC7A11—forelimb zeugopod—head and neck cancer	0.0616	0.26	CbGeAlD
Acetylcysteine—Erythema facial—Hydroxyurea—head and neck cancer	0.0272	0.181	CcSEcCtD
Acetylcysteine—SLC7A11—tongue—head and neck cancer	0.0166	0.0699	CbGeAlD
Acetylcysteine—GSS—hair follicle—head and neck cancer	0.0115	0.0485	CbGeAlD
Acetylcysteine—SLC7A11—mouth—head and neck cancer	0.0111	0.047	CbGeAlD
Acetylcysteine—GSS—mouth—head and neck cancer	0.00902	0.0381	CbGeAlD
Acetylcysteine—Gastrointestinal symptom NOS—Hydroxyurea—head and neck cancer	0.00846	0.0563	CcSEcCtD
Acetylcysteine—CHUK—connective tissue—head and neck cancer	0.00829	0.035	CbGeAlD
Acetylcysteine—ACY1—thyroid gland—head and neck cancer	0.00797	0.0337	CbGeAlD
Acetylcysteine—CHUK—epithelium—head and neck cancer	0.00787	0.0332	CbGeAlD
Acetylcysteine—ACY1—head—head and neck cancer	0.00707	0.0299	CbGeAlD
Acetylcysteine—GSS—parotid gland—head and neck cancer	0.00628	0.0265	CbGeAlD
Acetylcysteine—Gastrointestinal symptom NOS—Fluorouracil—head and neck cancer	0.00609	0.0405	CcSEcCtD
Acetylcysteine—CHUK—lymphoid tissue—head and neck cancer	0.00606	0.0256	CbGeAlD
Acetylcysteine—GSS—saliva-secreting gland—head and neck cancer	0.00602	0.0254	CbGeAlD
Acetylcysteine—IKBKB—connective tissue—head and neck cancer	0.00563	0.0238	CbGeAlD
Acetylcysteine—Chest tightness—Docetaxel—head and neck cancer	0.00551	0.0367	CcSEcCtD
Acetylcysteine—CHUK—thyroid gland—head and neck cancer	0.0055	0.0232	CbGeAlD
Acetylcysteine—GRIN2D—head—head and neck cancer	0.00501	0.0211	CbGeAlD
Acetylcysteine—CHUK—head—head and neck cancer	0.00488	0.0206	CbGeAlD
Acetylcysteine—GRIN3A—head—head and neck cancer	0.00471	0.0199	CbGeAlD
Acetylcysteine—GSS—trachea—head and neck cancer	0.00464	0.0196	CbGeAlD
Acetylcysteine—SLC7A11—thyroid gland—head and neck cancer	0.00453	0.0191	CbGeAlD
Acetylcysteine—GRIN1—head—head and neck cancer	0.00447	0.0188	CbGeAlD
Acetylcysteine—GRIN2B—head—head and neck cancer	0.00426	0.018	CbGeAlD
Acetylcysteine—IKBKB—lymphoid tissue—head and neck cancer	0.00412	0.0174	CbGeAlD
Acetylcysteine—SLC7A11—head—head and neck cancer	0.00402	0.017	CbGeAlD
Acetylcysteine—IKBKB—thyroid gland—head and neck cancer	0.00374	0.0158	CbGeAlD
Acetylcysteine—GRIN2A—head—head and neck cancer	0.00372	0.0157	CbGeAlD
Acetylcysteine—GSS—thyroid gland—head and neck cancer	0.00367	0.0155	CbGeAlD
Acetylcysteine—Face oedema—Hydroxyurea—head and neck cancer	0.00349	0.0232	CcSEcCtD
Acetylcysteine—CHUK—lymph node—head and neck cancer	0.00342	0.0144	CbGeAlD
Acetylcysteine—IKBKB—head—head and neck cancer	0.00332	0.014	CbGeAlD
Acetylcysteine—GSS—head—head and neck cancer	0.00326	0.0138	CbGeAlD
Acetylcysteine—Rhinorrhoea—Docetaxel—head and neck cancer	0.00319	0.0212	CcSEcCtD
Acetylcysteine—Chest discomfort—Docetaxel—head and neck cancer	0.00292	0.0194	CcSEcCtD
Acetylcysteine—Drowsiness—Hydroxyurea—head and neck cancer	0.00278	0.0185	CcSEcCtD
Acetylcysteine—Pharyngitis—Vinblastine—head and neck cancer	0.00272	0.0181	CcSEcCtD
Acetylcysteine—Stomatitis—Hydroxyurea—head and neck cancer	0.00271	0.0181	CcSEcCtD
Acetylcysteine—Nasopharyngitis—Fluorouracil—head and neck cancer	0.00232	0.0155	CcSEcCtD
Acetylcysteine—IKBKB—lymph node—head and neck cancer	0.00232	0.00981	CbGeAlD
Acetylcysteine—GSS—lymph node—head and neck cancer	0.00228	0.00963	CbGeAlD
Acetylcysteine—Angiopathy—Hydroxyurea—head and neck cancer	0.00227	0.0151	CcSEcCtD
Acetylcysteine—Erythema—Hydroxyurea—head and neck cancer	0.00218	0.0145	CcSEcCtD
Acetylcysteine—Stomatitis—Fluorouracil—head and neck cancer	0.00195	0.013	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00184	0.0122	CcSEcCtD
Acetylcysteine—Pharyngitis—Fluorouracil—head and neck cancer	0.00179	0.0119	CcSEcCtD
Acetylcysteine—Oedema—Hydroxyurea—head and neck cancer	0.00178	0.0118	CcSEcCtD
Acetylcysteine—Skin disorder—Hydroxyurea—head and neck cancer	0.00172	0.0115	CcSEcCtD
Acetylcysteine—Nasopharyngitis—Docetaxel—head and neck cancer	0.00168	0.0112	CcSEcCtD
Acetylcysteine—Bronchospasm—Docetaxel—head and neck cancer	0.0016	0.0106	CcSEcCtD
Acetylcysteine—Dyspnoea—Hydroxyurea—head and neck cancer	0.00158	0.0105	CcSEcCtD
Acetylcysteine—Somnolence—Hydroxyurea—head and neck cancer	0.00158	0.0105	CcSEcCtD
Acetylcysteine—Erythema—Fluorouracil—head and neck cancer	0.00157	0.0104	CcSEcCtD
Acetylcysteine—Dyspepsia—Hydroxyurea—head and neck cancer	0.00156	0.0104	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00153	0.0102	CcSEcCtD
Acetylcysteine—Hypersensitivity—Vinblastine—head and neck cancer	0.00143	0.00955	CcSEcCtD
Acetylcysteine—Stomatitis—Docetaxel—head and neck cancer	0.00141	0.00938	CcSEcCtD
Acetylcysteine—Body temperature increased—Hydroxyurea—head and neck cancer	0.0014	0.00934	CcSEcCtD
Acetylcysteine—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00131	0.00871	CcSEcCtD
Acetylcysteine—Pharyngitis—Docetaxel—head and neck cancer	0.00129	0.00858	CcSEcCtD
Acetylcysteine—Dizziness—Vinblastine—head and neck cancer	0.00129	0.00857	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00128	0.00851	CcSEcCtD
Acetylcysteine—Oedema—Fluorouracil—head and neck cancer	0.00128	0.00851	CcSEcCtD
Acetylcysteine—Tachycardia—Fluorouracil—head and neck cancer	0.00125	0.0083	CcSEcCtD
Acetylcysteine—Vomiting—Vinblastine—head and neck cancer	0.00124	0.00824	CcSEcCtD
Acetylcysteine—Flushing—Docetaxel—head and neck cancer	0.0012	0.00802	CcSEcCtD
Acetylcysteine—Cardiac disorder—Docetaxel—head and neck cancer	0.0012	0.00802	CcSEcCtD
Acetylcysteine—Hypotension—Fluorouracil—head and neck cancer	0.00119	0.00795	CcSEcCtD
Acetylcysteine—Angiopathy—Docetaxel—head and neck cancer	0.00118	0.00784	CcSEcCtD
Acetylcysteine—Dizziness—Hydroxyurea—head and neck cancer	0.00117	0.00781	CcSEcCtD
Acetylcysteine—Immune system disorder—Docetaxel—head and neck cancer	0.00117	0.00781	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Docetaxel—head and neck cancer	0.00117	0.00779	CcSEcCtD
Acetylcysteine—Nausea—Vinblastine—head and neck cancer	0.00116	0.0077	CcSEcCtD
Acetylcysteine—Dyspnoea—Fluorouracil—head and neck cancer	0.00114	0.00758	CcSEcCtD
Acetylcysteine—Somnolence—Fluorouracil—head and neck cancer	0.00114	0.00756	CcSEcCtD
Acetylcysteine—Erythema—Docetaxel—head and neck cancer	0.00113	0.00752	CcSEcCtD
Acetylcysteine—Vomiting—Hydroxyurea—head and neck cancer	0.00113	0.00751	CcSEcCtD
Acetylcysteine—Dyspepsia—Fluorouracil—head and neck cancer	0.00112	0.00749	CcSEcCtD
Acetylcysteine—Rash—Hydroxyurea—head and neck cancer	0.00112	0.00745	CcSEcCtD
Acetylcysteine—Dermatitis—Hydroxyurea—head and neck cancer	0.00112	0.00744	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.0011	0.00734	CcSEcCtD
Acetylcysteine—Nausea—Hydroxyurea—head and neck cancer	0.00105	0.00702	CcSEcCtD
Acetylcysteine—Urticaria—Fluorouracil—head and neck cancer	0.00102	0.00676	CcSEcCtD
Acetylcysteine—Syncope—Docetaxel—head and neck cancer	0.00101	0.00675	CcSEcCtD
Acetylcysteine—Body temperature increased—Fluorouracil—head and neck cancer	0.00101	0.00672	CcSEcCtD
Acetylcysteine—Loss of consciousness—Docetaxel—head and neck cancer	0.000993	0.00661	CcSEcCtD
Acetylcysteine—Cough—Docetaxel—head and neck cancer	0.000986	0.00656	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000955	0.00636	CcSEcCtD
Acetylcysteine—Hypersensitivity—Fluorouracil—head and neck cancer	0.000941	0.00627	CcSEcCtD
Acetylcysteine—Oedema—Docetaxel—head and neck cancer	0.000922	0.00614	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Docetaxel—head and neck cancer	0.000922	0.00614	CcSEcCtD
Acetylcysteine—Shock—Docetaxel—head and neck cancer	0.000907	0.00604	CcSEcCtD
Acetylcysteine—Pruritus—Fluorouracil—head and neck cancer	0.000904	0.00602	CcSEcCtD
Acetylcysteine—Tachycardia—Docetaxel—head and neck cancer	0.0009	0.00599	CcSEcCtD
Acetylcysteine—Skin disorder—Docetaxel—head and neck cancer	0.000896	0.00596	CcSEcCtD
Acetylcysteine—Hypotension—Docetaxel—head and neck cancer	0.000862	0.00574	CcSEcCtD
Acetylcysteine—Dizziness—Fluorouracil—head and neck cancer	0.000845	0.00563	CcSEcCtD
Acetylcysteine—Dyspnoea—Docetaxel—head and neck cancer	0.000822	0.00547	CcSEcCtD
Acetylcysteine—Somnolence—Docetaxel—head and neck cancer	0.00082	0.00546	CcSEcCtD
Acetylcysteine—Vomiting—Fluorouracil—head and neck cancer	0.000812	0.00541	CcSEcCtD
Acetylcysteine—Dyspepsia—Docetaxel—head and neck cancer	0.000812	0.0054	CcSEcCtD
Acetylcysteine—Rash—Fluorouracil—head and neck cancer	0.000806	0.00536	CcSEcCtD
Acetylcysteine—Dermatitis—Fluorouracil—head and neck cancer	0.000805	0.00536	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000796	0.0053	CcSEcCtD
Acetylcysteine—Nausea—Fluorouracil—head and neck cancer	0.000759	0.00505	CcSEcCtD
Acetylcysteine—Body temperature increased—Docetaxel—head and neck cancer	0.000729	0.00485	CcSEcCtD
Acetylcysteine—Hypersensitivity—Docetaxel—head and neck cancer	0.000679	0.00452	CcSEcCtD
Acetylcysteine—Pruritus—Docetaxel—head and neck cancer	0.000653	0.00434	CcSEcCtD
Acetylcysteine—Dizziness—Docetaxel—head and neck cancer	0.00061	0.00406	CcSEcCtD
Acetylcysteine—Vomiting—Docetaxel—head and neck cancer	0.000586	0.0039	CcSEcCtD
Acetylcysteine—Rash—Docetaxel—head and neck cancer	0.000582	0.00387	CcSEcCtD
Acetylcysteine—Dermatitis—Docetaxel—head and neck cancer	0.000581	0.00387	CcSEcCtD
Acetylcysteine—Nausea—Docetaxel—head and neck cancer	0.000548	0.00365	CcSEcCtD
Acetylcysteine—CHUK—Signaling by ERBB2—PIK3CA—head and neck cancer	0.000253	0.000414	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—MAPK1—head and neck cancer	0.000253	0.000413	CbGpPWpGaD
Acetylcysteine—CHUK—B Cell Activation—EGFR—head and neck cancer	0.000253	0.000413	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 signaling—PIK3CA—head and neck cancer	0.000252	0.000412	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signaling of activated FGFR—HRAS—head and neck cancer	0.000252	0.000411	CbGpPWpGaD
Acetylcysteine—GRIN1—Axon guidance—MAPK1—head and neck cancer	0.000249	0.000407	CbGpPWpGaD
Acetylcysteine—GRIN1—Axon guidance—EGFR—head and neck cancer	0.000249	0.000407	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—PIK3CA—head and neck cancer	0.000249	0.000406	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB4—HRAS—head and neck cancer	0.000248	0.000405	CbGpPWpGaD
Acetylcysteine—IKBKB—Fc epsilon receptor (FCERI) signaling—MAPK1—head and neck cancer	0.000248	0.000405	CbGpPWpGaD
Acetylcysteine—IKBKB—Fc epsilon receptor (FCERI) signaling—EGFR—head and neck cancer	0.000248	0.000404	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—IL2—head and neck cancer	0.000248	0.000404	CbGpPWpGaD
Acetylcysteine—GRIN2B—Axon guidance—MAPK1—head and neck cancer	0.000243	0.000396	CbGpPWpGaD
Acetylcysteine—GRIN2B—Axon guidance—EGFR—head and neck cancer	0.000243	0.000396	CbGpPWpGaD
Acetylcysteine—CHUK—NGF signalling via TRKA from the plasma membrane—MAPK1—head and neck cancer	0.000242	0.000395	CbGpPWpGaD
Acetylcysteine—CHUK—NGF signalling via TRKA from the plasma membrane—EGFR—head and neck cancer	0.000242	0.000395	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—KISS1—head and neck cancer	0.000238	0.000389	CbGpPWpGaD
Acetylcysteine—CHUK—Fc epsilon receptor (FCERI) signaling—PIK3CA—head and neck cancer	0.000237	0.000387	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 interactions—PIK3CA—head and neck cancer	0.000237	0.000387	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR in disease—PIK3CA—head and neck cancer	0.000237	0.000387	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signal transduction—HRAS—head and neck cancer	0.000237	0.000386	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR—HRAS—head and neck cancer	0.000236	0.000384	CbGpPWpGaD
Acetylcysteine—CHUK—Regulation of toll-like receptor signaling pathway—AKT1—head and neck cancer	0.000235	0.000384	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR—PIK3CA—head and neck cancer	0.000235	0.000384	CbGpPWpGaD
Acetylcysteine—IKBKB—BDNF signaling pathway—HRAS—head and neck cancer	0.000235	0.000383	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB2—HRAS—head and neck cancer	0.000234	0.000383	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 signaling—HRAS—head and neck cancer	0.000233	0.000381	CbGpPWpGaD
Acetylcysteine—IKBKB—Insulin Signaling—PIK3CA—head and neck cancer	0.000233	0.000381	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR in Cancer—PIK3CA—head and neck cancer	0.000233	0.00038	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by SCF-KIT—AKT1—head and neck cancer	0.000232	0.000379	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by PDGF—PIK3CA—head and neck cancer	0.000232	0.000379	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—HRAS—head and neck cancer	0.00023	0.000375	CbGpPWpGaD
Acetylcysteine—IKBKB—B Cell Activation—EGFR—head and neck cancer	0.000229	0.000374	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—PTEN—head and neck cancer	0.000229	0.000374	CbGpPWpGaD
Acetylcysteine—CHUK—BDNF signaling pathway—AKT1—head and neck cancer	0.000229	0.000373	CbGpPWpGaD
Acetylcysteine—GRIN1—Neuronal System—HRAS—head and neck cancer	0.000226	0.000368	CbGpPWpGaD
Acetylcysteine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—PIK3CA—head and neck cancer	0.000225	0.000368	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—BCL2L1—head and neck cancer	0.000225	0.000367	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—IL2—head and neck cancer	0.000225	0.000366	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	0.000223	0.000364	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signaling of activated FGFR—AKT1—head and neck cancer	0.000222	0.000363	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Breast Cancer Pathway—AKT1—head and neck cancer	0.00022	0.000359	CbGpPWpGaD
Acetylcysteine—GRIN2B—Neuronal System—HRAS—head and neck cancer	0.00022	0.000359	CbGpPWpGaD
Acetylcysteine—CHUK—B Cell Activation—PIK3CA—head and neck cancer	0.00022	0.000358	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—PIK3CA—head and neck cancer	0.00022	0.000358	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 interactions—HRAS—head and neck cancer	0.00022	0.000358	CbGpPWpGaD
Acetylcysteine—CHUK—Fc epsilon receptor (FCERI) signaling—HRAS—head and neck cancer	0.00022	0.000358	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR in disease—HRAS—head and neck cancer	0.00022	0.000358	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB4—AKT1—head and neck cancer	0.000219	0.000357	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR—HRAS—head and neck cancer	0.000218	0.000355	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—TP53—head and neck cancer	0.000217	0.000354	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—KISS1—head and neck cancer	0.000216	0.000353	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	0.000216	0.000352	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000216	0.000352	CbGpPWpGaD
Acetylcysteine—IKBKB—Insulin Signaling—HRAS—head and neck cancer	0.000216	0.000352	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR in Cancer—HRAS—head and neck cancer	0.000216	0.000352	CbGpPWpGaD
Acetylcysteine—IKBKB—Fc epsilon receptor (FCERI) signaling—PIK3CA—head and neck cancer	0.000215	0.000351	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by PDGF—HRAS—head and neck cancer	0.000215	0.00035	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000214	0.000349	CbGpPWpGaD
Acetylcysteine—IKBKB—Regulation of toll-like receptor signaling pathway—AKT1—head and neck cancer	0.000213	0.000348	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—TP53—head and neck cancer	0.000212	0.000347	CbGpPWpGaD
Acetylcysteine—CHUK—NGF signalling via TRKA from the plasma membrane—PIK3CA—head and neck cancer	0.00021	0.000343	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signal transduction—AKT1—head and neck cancer	0.000209	0.000341	CbGpPWpGaD
Acetylcysteine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—HRAS—head and neck cancer	0.000209	0.00034	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—STAT3—head and neck cancer	0.000208	0.00034	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR—AKT1—head and neck cancer	0.000208	0.000339	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—PTEN—head and neck cancer	0.000208	0.000339	CbGpPWpGaD
Acetylcysteine—IKBKB—BDNF signaling pathway—AKT1—head and neck cancer	0.000207	0.000338	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by ERBB2—AKT1—head and neck cancer	0.000207	0.000338	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 signaling—AKT1—head and neck cancer	0.000206	0.000336	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—STAT3—head and neck cancer	0.000205	0.000334	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—BCL2L1—head and neck cancer	0.000204	0.000333	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—NAT2—head and neck cancer	0.000203	0.000332	CbGpPWpGaD
Acetylcysteine—CHUK—B Cell Activation—HRAS—head and neck cancer	0.000203	0.000331	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—HRAS—head and neck cancer	0.000203	0.000331	CbGpPWpGaD
Acetylcysteine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—AKT1—head and neck cancer	0.000203	0.000331	CbGpPWpGaD
Acetylcysteine—GRIN1—Axon guidance—HRAS—head and neck cancer	0.0002	0.000326	CbGpPWpGaD
Acetylcysteine—ACY1—Metabolism—PIK3CA—head and neck cancer	0.000199	0.000325	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—MAPK3—head and neck cancer	0.000199	0.000325	CbGpPWpGaD
Acetylcysteine—IKBKB—B Cell Activation—PIK3CA—head and neck cancer	0.000199	0.000325	CbGpPWpGaD
Acetylcysteine—IKBKB—Fc epsilon receptor (FCERI) signaling—HRAS—head and neck cancer	0.000199	0.000325	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—VEGFA—head and neck cancer	0.000198	0.000322	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—GRP—head and neck cancer	0.000196	0.00032	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—MAPK3—head and neck cancer	0.000196	0.000319	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—STAT3—head and neck cancer	0.000196	0.000319	CbGpPWpGaD
Acetylcysteine—GRIN2B—Axon guidance—HRAS—head and neck cancer	0.000195	0.000318	CbGpPWpGaD
Acetylcysteine—CHUK—NGF signalling via TRKA from the plasma membrane—HRAS—head and neck cancer	0.000194	0.000317	CbGpPWpGaD
Acetylcysteine—CHUK—Fc epsilon receptor (FCERI) signaling—AKT1—head and neck cancer	0.000194	0.000316	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by FGFR in disease—AKT1—head and neck cancer	0.000194	0.000316	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 interactions—AKT1—head and neck cancer	0.000194	0.000316	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—VEGFA—head and neck cancer	0.000193	0.000314	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR—AKT1—head and neck cancer	0.000192	0.000313	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—STAT3—head and neck cancer	0.000191	0.000311	CbGpPWpGaD
Acetylcysteine—IKBKB—Insulin Signaling—AKT1—head and neck cancer	0.000191	0.000311	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—STAT6—head and neck cancer	0.000191	0.000311	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by EGFR in Cancer—AKT1—head and neck cancer	0.00019	0.000311	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by PDGF—AKT1—head and neck cancer	0.00019	0.000309	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—MAPK1—head and neck cancer	0.000189	0.000309	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—STAT3—head and neck cancer	0.000189	0.000308	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—MAPK3—head and neck cancer	0.000187	0.000305	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—MAPK1—head and neck cancer	0.000186	0.000304	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—EGFR—head and neck cancer	0.000186	0.000304	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—PTGS2—head and neck cancer	0.000186	0.000304	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—STAT3—head and neck cancer	0.000186	0.000303	CbGpPWpGaD
Acetylcysteine—IKBKB—B Cell Activation—HRAS—head and neck cancer	0.000184	0.000301	CbGpPWpGaD
Acetylcysteine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—AKT1—head and neck cancer	0.000184	0.0003	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—CASP8—head and neck cancer	0.000184	0.0003	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—AKT1—head and neck cancer	0.000183	0.000299	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	0.000182	0.000298	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—MAPK3—head and neck cancer	0.000182	0.000297	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—MAPK3—head and neck cancer	0.000181	0.000295	CbGpPWpGaD
Acetylcysteine—CHUK—B Cell Activation—AKT1—head and neck cancer	0.000179	0.000293	CbGpPWpGaD
Acetylcysteine—SLC7A11—Hemostasis—AKT1—head and neck cancer	0.000179	0.000293	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—DPYD—head and neck cancer	0.000178	0.000291	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—GRP—head and neck cancer	0.000178	0.00029	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—MAPK1—head and neck cancer	0.000178	0.00029	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—EGFR—head and neck cancer	0.000178	0.00029	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—MAPK3—head and neck cancer	0.000178	0.00029	CbGpPWpGaD
Acetylcysteine—IKBKB—Fc epsilon receptor (FCERI) signaling—AKT1—head and neck cancer	0.000176	0.000287	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—CDH1—head and neck cancer	0.000174	0.000285	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—MAPK1—head and neck cancer	0.000173	0.000283	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—EGFR—head and neck cancer	0.000173	0.000283	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—STAT6—head and neck cancer	0.000173	0.000282	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—MAPK1—head and neck cancer	0.000172	0.00028	CbGpPWpGaD
Acetylcysteine—CHUK—NGF signalling via TRKA from the plasma membrane—AKT1—head and neck cancer	0.000172	0.00028	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—YAP1—head and neck cancer	0.000169	0.000276	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—MAPK1—head and neck cancer	0.000169	0.000276	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—EGFR—head and neck cancer	0.000169	0.000276	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—YAP1—head and neck cancer	0.000169	0.000275	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—CASP8—head and neck cancer	0.000167	0.000272	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—PIK3CA—head and neck cancer	0.000164	0.000268	CbGpPWpGaD
Acetylcysteine—ACY1—Metabolism—AKT1—head and neck cancer	0.000163	0.000266	CbGpPWpGaD
Acetylcysteine—IKBKB—B Cell Activation—AKT1—head and neck cancer	0.000163	0.000265	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—PTEN—head and neck cancer	0.000162	0.000265	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—PIK3CA—head and neck cancer	0.000162	0.000264	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—CDH1—head and neck cancer	0.000158	0.000258	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—BCL2—head and neck cancer	0.000158	0.000257	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—YAP1—head and neck cancer	0.000153	0.000249	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—HRAS—head and neck cancer	0.000152	0.000248	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—HRAS—head and neck cancer	0.00015	0.000244	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—PIK3CA—head and neck cancer	0.000149	0.000243	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—PIK3CA—head and neck cancer	0.000147	0.000239	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—BCL2—head and neck cancer	0.000143	0.000233	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—HRAS—head and neck cancer	0.000143	0.000233	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—HRAS—head and neck cancer	0.000139	0.000227	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—HRAS—head and neck cancer	0.000138	0.000225	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—HRAS—head and neck cancer	0.000136	0.000221	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by NGF—AKT1—head and neck cancer	0.000132	0.000215	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—BCL2L1—head and neck cancer	0.000131	0.000214	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—PTEN—head and neck cancer	0.000131	0.000213	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	0.000127	0.000207	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—AKT1—head and neck cancer	0.000126	0.000206	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—PTEN—head and neck cancer	0.000125	0.000205	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—AKT1—head and neck cancer	0.000123	0.000201	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by NGF—AKT1—head and neck cancer	0.00012	0.000195	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—BCL2L1—head and neck cancer	0.000119	0.000194	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—PTEN—head and neck cancer	0.000118	0.000193	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—PIK3CA—head and neck cancer	0.000114	0.000187	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—PTEN—head and neck cancer	0.000114	0.000186	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—MAPK3—head and neck cancer	0.000112	0.000182	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	0.000111	0.000181	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—NOTCH1—head and neck cancer	0.000109	0.000177	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CASP8—head and neck cancer	0.000107	0.000175	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—MAPK1—head and neck cancer	0.000106	0.000173	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—EGFR—head and neck cancer	0.000106	0.000173	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CDH1—head and neck cancer	0.000106	0.000173	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—EGFR—head and neck cancer	0.000102	0.000166	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—TYMS—head and neck cancer	0.000102	0.000166	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—MAPK3—head and neck cancer	0.000101	0.000165	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—GSTM1—head and neck cancer	0.0001	0.000164	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CASP8—head and neck cancer	9.71e-05	0.000158	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—MAPK1—head and neck cancer	9.63e-05	0.000157	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—EGFR—head and neck cancer	9.63e-05	0.000157	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—GPX1—head and neck cancer	9.61e-05	0.000157	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CDH1—head and neck cancer	9.59e-05	0.000157	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—CYP1A1—head and neck cancer	9.52e-05	0.000155	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—AKT1—head and neck cancer	9.35e-05	0.000153	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—EGFR—head and neck cancer	9.25e-05	0.000151	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—PIK3CA—head and neck cancer	9.22e-05	0.00015	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—BCL2—head and neck cancer	9.19e-05	0.00015	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—PIK3CA—head and neck cancer	8.85e-05	0.000144	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—HRAS—head and neck cancer	8.53e-05	0.000139	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—PIK3CA—head and neck cancer	8.36e-05	0.000136	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—BCL2—head and neck cancer	8.33e-05	0.000136	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—HRAS—head and neck cancer	8.19e-05	0.000134	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IL2—head and neck cancer	8.09e-05	0.000132	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PTGS2—head and neck cancer	8.06e-05	0.000131	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—PIK3CA—head and neck cancer	8.03e-05	0.000131	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	7.82e-05	0.000128	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—HRAS—head and neck cancer	7.73e-05	0.000126	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—PTEN—head and neck cancer	7.61e-05	0.000124	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—NOTCH1—head and neck cancer	7.6e-05	0.000124	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—AKT1—head and neck cancer	7.53e-05	0.000123	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—HRAS—head and neck cancer	7.43e-05	0.000121	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IL2—head and neck cancer	7.33e-05	0.00012	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—AKT1—head and neck cancer	7.23e-05	0.000118	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PTEN—head and neck cancer	7.03e-05	0.000115	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—PTEN—head and neck cancer	6.9e-05	0.000113	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—NOTCH1—head and neck cancer	6.89e-05	0.000112	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—AKT1—head and neck cancer	6.83e-05	0.000111	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—STAT3—head and neck cancer	6.81e-05	0.000111	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—AKT1—head and neck cancer	6.56e-05	0.000107	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—MAPK3—head and neck cancer	6.5e-05	0.000106	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—STAT3—head and neck cancer	6.28e-05	0.000103	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—MAPK1—head and neck cancer	6.19e-05	0.000101	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—EGFR—head and neck cancer	6.19e-05	0.000101	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—STAT3—head and neck cancer	6.17e-05	0.000101	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—MAPK3—head and neck cancer	6e-05	9.8e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—MAPK3—head and neck cancer	5.9e-05	9.62e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—MAPK1—head and neck cancer	5.71e-05	9.32e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—EGFR—head and neck cancer	5.71e-05	9.32e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PTGS2—head and neck cancer	5.66e-05	9.24e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—MAPK1—head and neck cancer	5.61e-05	9.16e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—EGFR—head and neck cancer	5.61e-05	9.15e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—PIK3CA—head and neck cancer	5.37e-05	8.76e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—IL2—head and neck cancer	5.23e-05	8.53e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—CCND1—head and neck cancer	5.1e-05	8.32e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—HRAS—head and neck cancer	4.97e-05	8.11e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—PIK3CA—head and neck cancer	4.96e-05	8.09e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PTEN—head and neck cancer	4.94e-05	8.05e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PTEN—head and neck cancer	4.92e-05	8.03e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—PIK3CA—head and neck cancer	4.87e-05	7.94e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—IL2—head and neck cancer	4.74e-05	7.74e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—CCND1—head and neck cancer	4.62e-05	7.54e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—HRAS—head and neck cancer	4.59e-05	7.48e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—HRAS—head and neck cancer	4.5e-05	7.35e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PTEN—head and neck cancer	4.46e-05	7.28e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—VEGFA—head and neck cancer	4.44e-05	7.25e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—STAT3—head and neck cancer	4.4e-05	7.18e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—AKT1—head and neck cancer	4.39e-05	7.16e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MAPK3—head and neck cancer	4.2e-05	6.86e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—AKT1—head and neck cancer	4.05e-05	6.61e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—VEGFA—head and neck cancer	4.03e-05	6.58e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MAPK1—head and neck cancer	4e-05	6.53e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—EGFR—head and neck cancer	4e-05	6.53e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—STAT3—head and neck cancer	3.99e-05	6.51e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—AKT1—head and neck cancer	3.98e-05	6.49e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MAPK3—head and neck cancer	3.81e-05	6.22e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MAPK1—head and neck cancer	3.63e-05	5.92e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—EGFR—head and neck cancer	3.63e-05	5.92e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—PIK3CA—head and neck cancer	3.48e-05	5.68e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PIK3CA—head and neck cancer	3.47e-05	5.66e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—TP53—head and neck cancer	3.36e-05	5.48e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—HRAS—head and neck cancer	3.21e-05	5.24e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PIK3CA—head and neck cancer	3.15e-05	5.14e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—TP53—head and neck cancer	3.05e-05	4.97e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—HRAS—head and neck cancer	2.91e-05	4.75e-05	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—AKT1—head and neck cancer	2.84e-05	4.64e-05	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—AKT1—head and neck cancer	2.84e-05	4.63e-05	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—AKT1—head and neck cancer	2.57e-05	4.2e-05	CbGpPWpGaD
